Miami, FL – January 7, 2021 – EMAILWIRE – Bonne Santé Group, Inc., or BSG, an emerging growth Health & Wellness company in the nutraceutical sector, announced today that it has engaged Alan Bergman, CPA as Chief Financial Officer effective January 1, 2021. The announcement was made by A.J. Cervantes, Jr., Bonne Santé Group's Executive Chairman. "As Bonne Santé Group is on a path to public status in 2021, Alan's deep public company experience is invaluable in the execution of our strategic initiatives," stated Mr. Cervantes. "In addition to his accounting expertise, his finance knowledge and experience will not only serve to support but help drive our proactive acquisition strategies." Mr. Bergman brings to BSG a successful financial history in both the public and private sectors, having commenced his career at Deloitte & Touche LLP in 2000. His career path includes Senior Auditor at Weinberg & Company, P.A.; Audit Manager at Mallah Furman, P.A.; Vice President Finance at Latitude Solutions; Controller for Woodfield Distribution; Vice President Finance at Greenlane Holdings, Inc. (NASDAQ: GNLN), and, most recently, Chief Financial Officer, Vice President Finance at Bright Mountain Media, Inc. (OTCQB: BMTM). In addition, Mr. Bergman is also an Adjunct Professor of Accounting at Florida Atlantic University and Millennia Atlantic University. "I'm pleased to join the Bonne Santé management team," said Mr. Bergman. "BSG has created a formidable management team for such an early-stage company and working with A.J. Cervantes, Ryan Zackon, the Company's recently named Chief Executive Officer, and Darren Minton, BSG's President, I know we will be able to create a world class publicly-held nutraceutical company." Ryan Zackon, BSG's Chief Executive Officer, noted, "I've known Alan since 2016 and I am pleased to welcome him to our leadership team. Alan's extensive experience in the complex space of domestic and cross-border acquisitions, paired with his deep understanding of the financial operations within publicly held companies will make an immediate impact as we move quickly through our robust target pipeline and continue to position the Bonne Santé Group for an IPO." About Bonne Santé Group, Inc. Bonne Santé Group, Inc. is an emerging growth global nutraceutical company. Structured as a holding company, BSG is executing a buy and build strategy with planned serial accretive acquisitions. BSG is engaged in the acquisition, operation and sale of a broad spectrum of nutraceutical and related products. To drive growth and earnings, the Company will develop proprietary products as well as acquire other brands. The management team and the board of directors of Bonne Santé have an objective of creating a major international nutraceutical and related products company, manufacturing, and marketing a wide range of world-class nutraceutical products and next-generation delivery technologies. Bonne Santé Group's platform company, Bonne Santé Natural Manufacturing ("BSNM"), operates from a 22,000 square-foot, FDA-certified, state-of-the-art facility in Doral, Florida where it manufactures an extensive line of nutraceutical products with a particular focus on capsules and tablets. Bonne Santé Group purchased BSNM, with over 20 years of operations, in 2018. BSNM has evolved into a comprehensive nutraceutical contract and private label manufacturing company. BSNM has established its success on sound business relationships with hundreds of clients over the years, who are located around the world, including the United States, South and Central America, and Europe. View Bonne Santé Natural Manufacturing's overview video here. For more information, please visit: www.bonnesantegroup.com Forward-Looking Statements This press release contains forward-looking statements and is subject to risks and uncertainties. All statements other than statements of historical fact or relating to present facts or current conditions included in this press release are forward-looking statements. Forward-looking statements give our current reasonable expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as "anticipate," "estimate," "expect," "project," "plan," "intend," "believe," "may," "should," "can have," "likely" and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. The forward-looking statements contained in this press release are based on reasonable assumptions we have made in light of our industry experience, perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances. As you read and consider this press release you should understand that these statements are not guarantees of performance or results. They involve risks, uncertainties (many of which are beyond our control) and assumptions. Although we believe that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect our actual operating and financial performance and cause our performance to differ materially from the performance anticipated in the forward-looking statements. Should one or more of these risks or uncertainties materialize or should any of these assumptions prove incorrect or change, our actual operating and financial performance may vary in material respects from the performance projected in these forward-looking statements. Any forward-looking statement made by us in this press release speaks only as of the date of this press release. Factors or events that could cause our actual operating and financial performance to differ, include those that will be provided to investors through our investor portal and additional risk factors may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Contact Information: A.J. Cervantes, Jr. Executive Chairman Bonne Santé Group, Inc. 10575 NW 37th Terrace Doral, FL 33178 786.749.1221 info@bonnesantegroup.com The information contained in this communication is confidential and intended only for the use of the named party above. This transmission may be legally privileged and if the reader of this message is not the intended recipient, this warning will serve as notice that any dissemination, distribution, or copying of this communication, or any of its contents, is strictly prohibited. If you have received this communication in error, accidentally or otherwise please return it to the sender immediately and delete the message from your hard drive. IMPORTANT NOTICES The information set forth above includes statements, estimates, projections with respect to our anticipated future performance and other forward-looking statements, which are subject to risks, uncertainties and assumptions. In some cases, you can identify these statements by forward-looking words such as "may", "might", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential", "future" or "continue", the negative of these terms and other comparable terminology. Such forward-looking statements are based on current plans, estimates and expectations and are made pursuant to the Private Securities Litigation Reform Act of 1995. These statements, estimates and projections are based upon various assumptions that we made concerning our anticipated results and industry trends, which may or may not occur. We are not making any representations as to the accuracy of these statements, estimates or projections. Our actual performance may be materially different from the statements, estimates or projections set forth below. We are under no duty to update any of these forward-looking statements to conform them to actual results or revised expectations. Neither this document nor any of its content constitutes an offer to sell, solicitation of an offer to buy or a recommendation for any security by Bonne Santé Group, Inc. (the "Company") or any third party. The content of this document is provided for general information purposes only and is not intended to solicit the purchase of securities or to be used as investment, legal or tax advice. A securities offering by the Company will only be made pursuant to a private placement memorandum and/or other subscription documents available elsewhere to prequalified prospective investors. The content of this document is qualified in its entirety by such offering materials. Prospective investors are urged to consult with their own, investment, legal and tax advisors prior to making any investment in the Company. Investing in private placements involves a high degree of risk. Securities sold through private placements are typically not publicly traded and, therefore, are less liquid. Additionally, investors may receive restricted stock that may be subject to holding period requirements. Companies seeking private placement investments tend to be in earlier stages of development and have not yet been fully tested in the public marketplace. Investing in private placements requires a tolerance for high risk, low liquidity, and a long-term commitment. Investors must be able to afford to lose their entire investment. Such investment products are not FDIC insured, may lose value, and have no bank guarantee.
This |
Comments
Post a Comment